Implications of Manganese in Chronic Acquired Hepatocerebral Degeneration.

The Liver Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom. Multi-Organ Transplant Unit, University Hospital, London, Canada. Toronto Centre for Liver Disease, Toronto General Hospital, Toronto, Canada. Electronic address: Jordan.Feld@uhn.ca.

Annals of hepatology. 2019;(1):274-278
Full text from:

Abstract

Neurological symptoms can be one of the over-riding symptoms in patients with liver cirrhosis. Patients can present with subtle changes in mood or neurological function due to hepatic encephalopathy (HE), to more severe presentations including stupor and coma. While HE, in its severe form, can be clinically easy to diagnose, more subtle forms may be more difficult to recognize. Other neurological diseases may indeed be overlooked in the context of cirrhosis or confuse the physician regarding the diagnosis. Chronic acquired hepatocerebral degeneration (CAHD) is an uncommon problem occurring in patients with cirrhosis characterised by a Parkinsonian-like neurological presentation with damage to the brain secondary to manganese (Mn) deposition. Here we describe a case of a patient with a neurological presentation of liver disease with a review of the current CAHD literature. In conclusion, CAHD is a rare condition occurring in liver cirrhosis that should always be considered in patients with neurological manifestations of chronic liver disease.

Methodological quality

Publication Type : Case Reports ; Review

Metadata

MeSH terms : Brain ; Manganese